Hypoglycaemia fear, treatment adherence, and the quality of life in patients with type 2 diabetes and its determinants.
hypoglycaemia fear
quality of life
treatment adherence
type 2 diabetes mellitus
Journal
International journal of nursing practice
ISSN: 1440-172X
Titre abrégé: Int J Nurs Pract
Pays: Australia
ID NLM: 9613615
Informations de publication
Date de publication:
22 Feb 2024
22 Feb 2024
Historique:
revised:
03
06
2023
received:
20
12
2022
accepted:
30
01
2024
medline:
22
2
2024
pubmed:
22
2
2024
entrez:
22
2
2024
Statut:
aheadofprint
Résumé
This work aims to evaluate the relationship between the fear of hypoglycaemia, treatment adherence, and the quality of life in patients with type 2 diabetes mellitus (T2DM) and its determinants. This descriptive and cross-sectional study sample recruited 1060 T2DM outpatients in a health centre between January and July 2022. The Hypoglycemia Fear Survey (HFS), Type 2 DM Treatment Patient Compliance Scale, and the 5-Level EuroQol 5-Dimension (EQ-5D-5L) were used for data collection. There was a positive correlation between age, duration of T2DM, and the scores obtained from the HFS and its subscales (p < 0.001). There was a positive, moderate correlation between the total HFS score and the TCS (p < 0.001). There was a negative correlation between the scores obtained from the HFS and the EQ-5D-5L (p < 0.001). The multiple regression analysis showed that the quality of life scores of the patients were significantly predicted by hypoglycaemia fear, duration of T2DM diagnosis, and age. (F = 91.691, p < 0.001). Hypoglycaemia fear, duration of T2DM diagnosis, and age explained 38.1% of the quality of life of patients. We determined that the increase in hypoglycaemia fear resulted in a decrease in treatment adherence. Besides, hypoglycaemia fear increased with increasing age and duration of T2DM diagnosis.
Types de publication
Journal Article
Langues
eng
Pagination
e13248Informations de copyright
© 2024 John Wiley & Sons Australia, Ltd.
Références
Anderbro, T. C., Amsberg, S., Moberg, E., Gonder-Frederick, L., Adamson, U., Lins, P. E., & Johansson, U. B. (2018). A longitudinal study of fear of hypoglycaemia in adults with type 1 diabetes. Endocrinology, Diabetes & Metabolism, 1(2), e00013. https://doi.org/10.1002/edm2.13
Baykal, A., & Kapucu, S. (2015). Type II diabetes mellitus patients' adherence to treatment. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi, 2(2), 44-58.
Bonikowska, I., Szwamel, K., & Uchmanowicz, I. (2021). Analysis of the impact of disease acceptance, demographic, and clinical variables on adherence to treatment recommendations in elderly type 2 diabetes mellitus patients. International Journal of Environmental Research and Public Health, 18(16), 8658. https://doi.org/10.3390/ijerph18168658
Cox, D. J., Irvine, A., Gonder-Frederick, L., Nowacek, G., & Butterfield, J. (1987). Fear of hypoglycemia: Quantification, validation, and utilization. Diabetes Care, 10(5), 617-621. https://doi.org/10.2337/diacare.10.5.617
Curkendall, S. M., Thomas, N., Bell, K. F., Juneau, P. L., & Weiss, A. J. (2013). Predictors of medication adherence in patients with type 2 diabetes mellitus. Current Medical Research and Opinion, 29(10), 1275-1286. https://doi.org/10.1185/03007995.2013.821056
Demirtaş, A., & Akbayrak, N. (2017). Development of an treatment compliance scale in type 2 diabetes mellitus in Turkish population: Psychometric evaluation. International Journal of Nursing Sciences, 4(3), 244-251. https://doi.org/10.1016/j.ijnss.2017.06.002
Erol, O., & Enc, N. (2011). Hypoglycemia fear and self-efficacy of Turkish patients receiving insulin therapy. Asian Nursing Research, 5(4), 222-228. https://doi.org/10.1016/j.anr.2011.12.001
Eser, E., Dinç, G., & Cambaz, S. (2007). Population standards and psychometric characteritics of EURO-QoL (EQ-5D) index: Manisa city population sample. In 2nd Quality of Life in Health Congress, İzmir, Turkey (Vol. 78).
Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39(2), 175-191. https://doi.org/10.3758/bf03193146
International Diabetes Federation Diabetes Atlas. (2022). Retrieved July 8, 2022, from https://diabetesatlas.org/
Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2020). Epidemiology of type 2 diabetes-global burden of disease and forecasted trends. Journal of Epidemiology and Global Health, 10(1), 107-111. https://doi.org/10.2991/jegh.k.191028.001
Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters-Weijnen, C., Forsén, T., Galstyan, G., Geelhoed-Duijvestijn, P., Goldfracht, M., Gydesen, H., Kapur, R., Lalic, N., Ludvik, B., Moberg, E., Pedersen-Bjergaard, U., Ramachandran, A., & HAT Investigator Group. (2016). Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: The global HAT study. Diabetes, Obesity and Metabolism, 18(9), 907-915. https://doi.org/10.1111/dom.12689
Kirkman, M. S., Rowan-Martin, M. T., Levin, R., Fonseca, V. A., Schmittdiel, J. A., Herman, W. H., & Aubert, R. E. (2015). Determinants of adherence to diabetes medications: Findings from a large pharmacy claims database. Diabetes Care, 38(4), 604-609. https://doi.org/10.2337/dc14-2098
Lajara, R., Cengiz, E., & Tanenberg, R. J. (2017). The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes. Current Medical Research and Opinion, 33(6), 1045-1055. https://doi.org/10.1080/03007995.2017.1298522
Midi, H., Sarkar, S. K., & Rana, S. (2010). Collinearity diagnostics of binary logistic regression model. Journal of Interdisciplinary Mathematics, 13(3), 253-267. https://doi.org/10.1080/09720502.2010.10700699
Muneer, M., & Akbar, I. (2021). Acute metabolic emergencies in diabetes: DKA, HHS and EDKA. Diabetes: from Research to Clinical Practice, 4, 85-114.
Omar, S., Albsoul, A., & Alabbadi, I. (2016). Hypoglycaemia fear among diabetics. Jordan Journal of Pharmaceutical Sciences, 9(2), 77-87.
Özkaptan, B. B., Kapucu, S., & Demirci, İ. (2019). Relationship between adherence to treatment and acceptance of illness in patients with type 2 diabetes. Cukurova Medical Journal, 44, 447-454. https://doi.org/10.17826/cumj.554402
Polonsky, W. H., Fisher, L., & Hessler, D. (2018). The impact of non-severe hypoglycemia on quality of life in patients with type 2 diabetes. Journal of Diabetes and its Complications, 32(4), 373-378. https://doi.org/10.1016/j.jdiacomp.2018.01.014
Polonsky, W. H., & Henry, R. R. (2016). Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Preference and Adherence, 22(10), 1299-1307. https://doi.org/10.2147/PPA.S106821
Reed, J., Bain, S., & Kanamarlapudi, V. (2021). A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 14, 3567-3602. https://doi.org/10.2147/DMSO.S319895
Ross, S. A., Tildesley, H. D., & Ashkenas, J. (2011). Barriers to effective insulin treatment: The persistence of poor glycemic control in type 2 diabetes. Current Medical Research and Opinion, 27(sup3), 13-20. https://doi.org/10.1185/03007995.2011.621416
Sakane, N., Kotani, K., Tsuzaki, K., Nishi, M., Takahashi, K., Murata, T., Yamada, K., Okazaki, K., Yanagisawa, K., Yamada, K., Kuribayashi, N., Totsuka, Y., Hiyoshi, T., Naka, M., Sugimoto, M., Aoki, Y., Waki, M., Furuya, M., Kitaoka, H., … Yamamoto, T. (2015). Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitus. Journal of Diabetes Investigation, 6(5), 567-570. https://doi.org/10.1111/jdi.12340
Satman, I., Omer, B., Tutuncu, Y., Kalaca, S., Gedik, S., Dinccag, N., Karsidag, K., Gernc, S., Telci, A., Canbaz, B., Turker, F., Yilmaz, T., Cakir, B., & Tuomilehto, J. (2013). Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. European Journal of Epidemiology, 28(2), 169-180. https://doi.org/10.1007/s10654-013-9771-5
Schmitt, A., Reimer, A., Kulzer, B., Icks, A., Paust, R., Roelver, K. M., Kaltheuner, M., Ehrmann, D., Krichbaum, M., Haak, T., & Hermanns, N. (2018). Measurement of psychological adjustment to diabetes with the diabetes acceptance scale. Journal of Diabetes and its Complications, 32(4), 384-392. https://doi.org/10.1016/j.jdiacomp.2018.01.005
Shi, L., Shao, H., Zhao, Y., & Thomas, N. A. (2014). Is hypoglycemia fear independently associated with health-related quality of life. Health and Quality of Life Outcomes, 12(1), 167. https://doi.org/10.1186/s12955-014-0167-3
Shiu, A. T., & Wong, R. Y. (2000). Fear of hypoglycaemia among insulin-treated Hong Kong Chinese patients: Implications for diabetes patient education. Patient Education and Counseling, 41(3), 251-261. https://doi.org/10.1016/S0738-3991(99)00084-1
Tabachnick, B. G., & Fidell, L. S. (2014). Using multivariate statistics (New International ed.). Pearson.
The EuroQol Group. (2009). Retrieved from https://euroqol.org/information-and-support/euroqol-instruments/eq-5d-5l
Vichayanrat, A., Matawaran, B. J., Wibudi, A., Ferdous, H. S., Aamir, A. H., Aggarwal, S. K., & Bajpai, S. (2013). Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study. Journal of Diabetes, 5(3), 309-318. https://doi.org/10.1111/1753-0407.12038
World Health Organisation. (2023). Adherence to long-term therapies: Evidence for action. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf
Yuksel, M., & Bektas, H. (2021). Compliance with treatment and fear of hypoglycaemia in patients with type 2 diabetes. Journal of Clinical Nursing, 30(11-12), 1773-1786. https://doi.org/10.1111/jocn.15736
Zoungas, S., Patel, A., Chalmers, J., De Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Grobbee, D. E., Kengne, A. P., Marra, M., Heller, S., & Advance Collaborative Group. (2010). Severe hypoglycemia and risks of vascular events and death. New England Journal of Medicine, 363(15), 1410-1418. https://doi.org/10.1056/NEJMoa1003795